Creegan & Nassoura Financial Group, LLC Johnson & Johnson Transaction History

Creegan & Nassoura Financial Group, LLC

$159 Million
Q3 2024

A detailed history of Creegan & Nassoura Financial Group, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Creegan & Nassoura Financial Group, LLC holds 16,715 shares of JNJ stock, worth $2.59 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares

16,715

Previous 16,767 0.31%

Holding current value

$2.59 Million

Previous $2.45 Million 10.53%

% of portfolio

1.71%

Previous 1.69%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $7,564 - $8,703	-52 Reduced 0.31%	16,715 $2.71 Million
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $28,876 - $31,556	-200 Reduced 1.18%	16,767 $2.45 Million
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $47,342 - $49,635	305 Added 1.83%	16,967 $2.68 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $42,831 - $47,982	-275 Reduced 1.62%	16,662 $2.6 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $801 - $898	-5 Reduced 0.03%	16,937 $2.99 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $4,033 - $4,488	-25 Reduced 0.15%	16,942 $2.77 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $14,127 - $15,624	-84 Reduced 0.49%	16,967 $3.01 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $158 - $179	1 Added 0.01%	17,051 $3.02 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $32,433 - $35,986	-208 Reduced 1.21%	17,050 $2.92 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $12,435 - $13,819	77 Added 0.45%	17,258 $2.79 Million
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $111,317 - $119,406	-698 Reduced 3.9%	17,181 $2.83 Million
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $53,421 - $59,497	-349 Reduced 1.91%	17,879 $2.94 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $13,573 - $15,580	-99 Reduced 0.54%	18,228 $2.87 Million
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $6,738 - $7,383	-48 Reduced 0.26%	18,327 $2.73 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $12,881 - $15,551	-100 Reduced 0.54%	18,375 $2.58 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $13,670 - $18,940	-123 Reduced 0.66%	18,475 $2.42 Million
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $2.37 Million - $2.72 Million	18,598 New	18,598 $2.71 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creegan & Nassoura Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Creegan & Nassoura Financial Group, LLC with notifications on news.

Account

Creegan & Nassoura Financial Group, LLC Johnson & Johnson Transaction History